Diabetic Drug Farxiga Emerges As A Potential Cause of Fournier's Gangrene

Diabetes Drug Infection Lawsuit News

The popular diabetic drug is gaining attention for allegedly causing Fournier's Gangrene, the genital-eating disease

Monday, July 20, 2020 - Diabetic patients taking Farxiga, one of the best-selling brands of diabetic medication, need to be made aware that the drug may cause Fournier's Gangrene, the genital flesh-eating disease. People with Fournier's Gangrene are faced with immediate hospitalization, normally lasting around three to four months, and surgical debridement of the rotting flesh around the anus, perineum, scrotum, and penis. Genital mutilation is common among those with the disease and can be a life-saver. Necrotizing fasciitis in the genital region may spread within days, even hours, and encompass the lower intestines, stomach bladder and lead to certain death. Immediate hospitalization is required if a patient is to have a chance of living.

Farxiga patients must monitor their genital region daily and watch for a signal that they may be developing the genital flesh-eating disease and then get to a hospital emergency room immediately. Stockhouse.com listed the early warning signs that Farxiga may have caused Fournier's Gangrene. " Cases have been reported in females and males. Serious outcomes have included hospitalization, surgeries, and death. Assess patients presenting with (early warning signs) pain or tenderness, erythema, swelling in the genital or perineal area, along with fever or malaise. If suspected, institute prompt treatment and discontinue FARXIGA" Diabetes drug infection lawyers offer a no obligation and free consultation should you or loved ones need advice or representation against big pharmaceutical corporations.

The product website has updated their product warning to include the term "Fournier's Gangrene," so there is no mistake about the drug's potentially devastating medical consequences. "Necrotizing Fasciitis of the Perineum (Fournier's Gangrene): Rare but serious, life-threatening cases have been reported in patients with diabetes mellitus receiving SGLT2 inhibitors including FARXIGA. Cases have been reported in females and males. Serious outcomes have included hospitalization, surgeries, and death."

Medical Xpress.com describes diabetic drugs that are included in the narrow class of regulating blood sugar levels and are taken by those that do not wish to test themselves and inject insulin daily. "SGLT2 inhibitors are a newer class of diabetes medications, introduced in 2013. Drugs in this class include canagliflozin (Invokana), dapagliflozin (Farxiga) and empagliflozin (Jardiance). Fournier gangrene occurred in 55 people taking these drugs between March 2013 and January 2019."

Drug companies have in the past rolled the dice with their Fournier's Gangrene product warning presumably because they believed that the disease was so rare. The disease may be many times more frequent, however, than the 55 cases linked to SGLT2 diabetic drugs that the US FDA discovered in 2016. Many times Fournier's Gangrene patients want anonymity because of embarrassment and also the disease can be overlooked as mistreatment by nursing homes that care for the elderly. AstraZeneca Inc., the maker of Farxiga, is being sued by an individual that has contracted Fournier's Gangrene allegedly from taking Farxiga. According to AboutLawsuits.com, "According to a recently filed product liability lawsuit, a Georgia man suffered a life-threatening, flesh-eating infection on his groin, known as Fournier's gangrene, which he alleges was caused by side effects of the diabetes drug Farxiga."

More Recent Diabetes Drug Infection Lawsuit News:

Lawyers for Fournier's Gangrene

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.